How to Estimate the Optimal Heart Rate in Patients with Heart Failure with Preserved Ejection Fraction

Abstract

Ideal heart rate (HR), particularly for those with heart failure with preserved ejection fraction (HFpEF), remains unknown. We hypothesized that cardiac output would be maximum when the overlap between E-wave and A-wave at the trans-mitral flow is "zero" in the Doppler echocardiography. We retrospectively investigated the association among the overlap length between two waves, actual HR, and other echocardiographic parameters to construct a formula for estimating theoretically ideal HR among those with HFpEF. In total, 48 HFpEF patients were included (70-year-olds, 18 males). Given the results of multivariate linear regression analyses, the overlap length was estimated as follows: 1,050 + 8.4 × (HR [bpm]) + 0.6 × (deceleration time [millisecond]) + 1.7 × (A-width [millisecond]), which had a strong agreement with the actually measured overlap length (r = 0.86, P < 0.001). Theoretically ideal HR was calculated by substituting zero into the estimated overlap length as follows: 125 − 0.07 × (deceleration time [millisecond]) − 0.20 × (A-width [millisecond]). In the validation cohort including another 143 HFpEF patients, the estimated overlap using the formula again had a strong agreement with the actually measured overlap (r = 0.72, P < 0.001). In this study, we proposed a novel formula for calculating theoretically ideal HR, consisting of deceleration time and A-width, in the HFpEF cohort. Clinical implication to optimize the HR targeting the theoretically ideal HR should be investigated in prospective studies.

Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis

“…Our team recently found that a "zero" overlap between E wave and A wave in the trans-mitral echocardiography flow was associated with maximum cardiac output and greater clinical outcomes in patients with systolic heart failure [7]. We expanded this concept and proposed formulas to estimate optimal HR using deceleration time alone for those with preserved ejection fraction (HFpEF) [7][8][9].…”

Combination therapy using tafamidis and neurohormonal blockers for cardiac amyloidosis and a reduced ejection fraction: a case report

“…In patients with diastolic dysfunction, the optimal heart rate might be relatively high, and aggressive beta-blocker therapy might reduce cardiac output. 10 The optimal medical therapy following the recovery of the LVEF, as found in our patient, also remains a future concern. Patisiran, which is currently used only for hereditary cardiac ATTR, might be more useful to achieve reverse remodeling than tafamidis.…”

Clinical Implications of Remote Dielectric Sensing-Guided Management

“…The presence of pulmonary congestion is associated with a significantly increased risk of cardiovascular mortality and morbidity in patients with acute-on-chronic heart failure [2]. The recent literature has shown that persistent elevations of ReDS values during index hospitalization were associated with a higher risk of all-cause death and incident heart failure hospitalization [12]. A previous retrospective study demonstrated that the post-discharge immediate measurement of ReDS values and medication adjustment was associated with a lower risk of 30-day cardiovascular admission [8].…”